164 related articles for article (PubMed ID: 2472386)
1. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.
Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA
J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386
[TBL] [Abstract][Full Text] [Related]
2. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.
Bayne ML; Applebaum J; Chicchi GG; Hayes NS; Green BG; Cascieri MA
J Biol Chem; 1988 May; 263(13):6233-9. PubMed ID: 2966152
[TBL] [Abstract][Full Text] [Related]
3. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor.
Cascieri MA; Chicchi GG; Applebaum J; Hayes NS; Green BG; Bayne ML
Biochemistry; 1988 May; 27(9):3229-33. PubMed ID: 2839228
[TBL] [Abstract][Full Text] [Related]
4. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors.
Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML
J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701
[TBL] [Abstract][Full Text] [Related]
5. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
[TBL] [Abstract][Full Text] [Related]
6. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor.
Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA
J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of DNA synthesis in chicken muscle satellite cells by insulin and insulin-like growth factors: evidence for exclusive mediation by a type-I insulin-like growth factor receptor.
Duclos MJ; Wilkie RS; Goddard C
J Endocrinol; 1991 Jan; 128(1):35-42. PubMed ID: 1847964
[TBL] [Abstract][Full Text] [Related]
8. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity.
Clemmons DR; Cascieri MA; Camacho-Hubner C; McCusker RH; Bayne ML
J Biol Chem; 1990 Jul; 265(21):12210-6. PubMed ID: 1695626
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
Cara JF; Nakagawa SH; Tager HS
Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
[TBL] [Abstract][Full Text] [Related]
10. Interaction of insulin-like growth factors (IGF) with isolated sheep hepatocytes. II. Binding, internalization and degradation of IGF-II.
Tandeski TR; Yemm RS; Hossner KL
Domest Anim Endocrinol; 1990 Jul; 7(3):353-63. PubMed ID: 2167813
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
12. Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins.
Pulford BE; Ishii DN
Endocrinology; 2001 Jan; 142(1):213-20. PubMed ID: 11145584
[TBL] [Abstract][Full Text] [Related]
13. Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity.
Zhang W; Gustafson TA; Rutter WJ; Johnson JD
J Biol Chem; 1994 Apr; 269(14):10609-13. PubMed ID: 8144650
[TBL] [Abstract][Full Text] [Related]
14. Interaction of insulin-like growth factors (IGF) with isolated sheep hepatocytes. I. Binding and degradation of IGF-I.
Tandeski TR; Yemm RS; Hossner KL
Domest Anim Endocrinol; 1990 Jul; 7(3):343-51. PubMed ID: 2167812
[TBL] [Abstract][Full Text] [Related]
15. Characterization of type II insulin-like growth factor (IGF) receptors in sheep liver plasma membranes.
Hossner KL; Yemm RS
Domest Anim Endocrinol; 1990 Apr; 7(2):207-16. PubMed ID: 2164459
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction.
Moss JA; Francis GL; Ross M; Wallace JC; Ballard FJ
J Biol Chem; 1991 Jan; 266(2):909-14. PubMed ID: 1702441
[TBL] [Abstract][Full Text] [Related]
17. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3.
Baxter RC; Bayne ML; Cascieri MA
J Biol Chem; 1992 Jan; 267(1):60-5. PubMed ID: 1370451
[TBL] [Abstract][Full Text] [Related]
19. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.
Ernst M; Rodan GA
Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921
[TBL] [Abstract][Full Text] [Related]
20. Inability of a mouse cell line transformed to produce biologically active recombinant human insulin-like growth factor I (IGF-I) to respond to exogenously added IGF-I.
Cascieri MA; Hayes NS; Kelder B; Kopchick JJ; Chicchi GG; Slater EE; Bayne ML
Endocrinology; 1988 Apr; 122(4):1314-20. PubMed ID: 2964361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
